Article
Worldwide Prevalence and Clinical Characteristics of RAS Mutations in Head and Neck Cancer: A Systematic Review and Meta-Analysis
2021-12-02
Abstract excerpt
<h4>Importance</h4> There is considerable variation among different studies for the prevalence of RAS mutations in head and neck cancer (HNC) patients. In light of the development of RAS inhibitors, a reliable assessment of the prevalence of RAS mutations and their correlation with the clinical features of patients with HNC is crucially needed. <h4>Objective</h4> To assess the worldwide prevalence of HRAS, KRAS, a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d8145757-683e-5fa1-b718-cd8cea875b23
- DOI
- 10.1101/2021.11.30.21267087
